Article

Which of your patients is more likely to need revision surgery after total hip replacement?

(AUDIO) Harvard orthopedic surgeon Jeffrey Katz discusses one of his recent studies that looked at risk factors for revision surgery after total hip replacement.

Which of your patients is more likely to need revision surgery after total hip replacement?

That’s the question we put to Dr Jeffrey Katz. In the next 5 minutes, Dr Katz will discuss one of his recent studies that looked at risk factors for revision surgery after total hip replacement.

Dr Katz is Professor of Medicine and Orthopedic Surgery, Harvard Medical School. He is a rheumatologist and clinical epidemiologist with over 20 years of clinical and research experience in osteoarthritis and the intersection of osteoarthritis and orthopedic surgery.

For more information: http://www6.aaos.org/news/pemr/releases/release.cfm?releasenum=967 

Which of your patients is more likely to need revision surgery after total hip replacement?

 

Related Videos
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
© 2024 MJH Life Sciences

All rights reserved.